Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer
ClinicalTrials.gov Identifier: NCT02494583.
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 1,036
- Institution
- Vall d'Hebron Institute of Oncology
External Links
Identifiers
- ORCID
- 0000-0003-4835-7159
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.